Drug news
Early trial for Retinitis Pigmentosa using microchip from Retina Implant AG
Two patients in a UK trial of the retinal implant, from Retina Implant AG, to treat Retinitis Pigmentosa have regained partial eyesight. The multi-centre phase of this trial expanded in 2011 to include additional sites in Germany, Hong Kong and the UK. Sites in Italy and Hungary are also under agreement to participate. The UK trials will include 12 patients in total and is being led by two centres: King�s College Hospital and the Oxford Eye Hospital.